Skye Bioscience Inc
NASDAQ:SKYE

Watchlist Manager
Skye Bioscience Inc Logo
Skye Bioscience Inc
NASDAQ:SKYE
Watchlist
Price: 5.31 USD -1.48% Market Closed
Market Cap: 161.1m USD
Have any thoughts about
Skye Bioscience Inc?
Write Note

Skye Bioscience Inc
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Skye Bioscience Inc
Common Shares Outstanding Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Skye Bioscience Inc
NASDAQ:SKYE
Common Shares Outstanding
$28.1m
CAGR 3-Years
161%
CAGR 5-Years
120%
CAGR 10-Years
98%
Abbvie Inc
NYSE:ABBV
Common Shares Outstanding
$1.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Common Shares Outstanding
$1.2B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Common Shares Outstanding
$537.5m
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Common Shares Outstanding
$257.7m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Common Shares Outstanding
$110.1m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%

See Also

What is Skye Bioscience Inc's Common Shares Outstanding?
Common Shares Outstanding
28.1m USD

Based on the financial report for Jun 30, 2024, Skye Bioscience Inc's Common Shares Outstanding amounts to 28.1m USD.

What is Skye Bioscience Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
98%

Over the last year, the Common Shares Outstanding growth was 622%. The average annual Common Shares Outstanding growth rates for Skye Bioscience Inc have been 161% over the past three years , 120% over the past five years , and 98% over the past ten years .

Back to Top